Role of Ilaj Bit Tadbeer (Regimenal Therapy) in Waja-ul-Mafasil (Osteoarthritis): A Review

Osteoarthritis is the commonest of all joint diseases. It results due to breakdown and destruction of joint tissues. The clinical picture of osteoarthritis strongly resembles with Waja-ul-Mafasil which has been elaborated in detail by Unani physicians. Considering the high prevalence, side effects of modern pharmacological treatment and high cost of surgical interventions with equivocal effectiveness of all treatment modalities, there is need for safe, economic and effective treatment in Unani Medicine for osteoarthritis. Unani System of Medicine has Ilaj Bit Tadbeer (Regimenal Therapy) as one of the modes of treatment. The Regimenal Therapy works on the principle of modifying or modulating the six essential factors (Asbaab-e-sittah zarooriya) for maintenance of health and prevention from diseases. Nowadays Regimenal Therapy holds an important place in Unani Medicine particularly for musculoskeletal and nervous disorders. The focus of this paper is to discuss and summarize the role of Ilaj bit Tadbeer in the management of Waja-ul-Mafasil. Key words: Osteoarthritis, Waja-ul-Mafasil, Unani System of Medicine, Ilaj Bit Tadbeer, Regimenal Therapy.

Introduction to the Patient with Rheumatic Disease

The rheumatic diseases encompass a broad spectrum of conditions that include inflammatory, metabolic, and structural diseases of the joints and adjacent musculoskeletal structures, chronic musculoskeletal pain syndromes, and a wide range of systemic autoimmune and autoinflammatory diseases that may or may not have articular manifestations. This review contains 4 figures, 13 tables, and 28 references. Key Words osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, fibromyalgia, acute monoarthritis, Ankylosing spondylitis, nonradiographic axial spondyloarthritis, gouty arthritis, lupus nephritis

Study on the importance of medical treatment and physical methods in recovering patients with knee osteoarthritis

Intrduction.Etoricoxibum belongs to the group of non-steroidal anti-inflammatory inhibitors selective of cyclooxygenase-2. The non-steroidal anti-inflammatory drugs are used to treat acute musculoskeletal disorders as they result in pain-relieving therapeutical effect. Etoricoxibum intervenes by blocking cyclooxygenase-2 and by reducing the painful and inflammatory phenomena. Material and method. The trial focused on the evolution of patients diagnosed with knee osteoarthritis after making the treatment by etoricoxibum. This study was conducted in the ambulatory regime for a period of 6 months and included 77 patients. Results and discussions It was assessed the efficacy of the complex recovery treatment for the patients diagnosed by knee osteoarthritis wich use of Etoricoxibum, in a dose of 60 mg /day, in order to improve the pain and the inflammation. The pursued objectives were: the assessment of the effects by using Etoricoxibum for the reduction of the pain and inflammation, the increase of the articular mobility and stability, the recovery of the walk and motor control, the decrease of the body weight, the increase of the quality of life. Conclusions. This trial show that, by making a combined treatment of medication and recovery, there was an reducing the pain and the inflammation as well as increasing the articular mobility. Key words: osteoarthritis, pain, ultrasound, recovery, disability,

Introduction to the Patient with Rheumatic Disease

The rheumatic diseases encompass a broad spectrum of conditions that include inflammatory, metabolic, and structural diseases of the joints and adjacent musculoskeletal structures, chronic musculoskeletal pain syndromes, and a wide range of systemic autoimmune and autoinflammatory diseases that may or may not have articular manifestations. This review contains 4 figures, 11 tables, and 25 references. Key Words osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, fibromyalgia, acute monoarthritis, Ankylosing spondylitis, nonradiographic axial spondyloarthritis, gouty arthritis, lupus nephritis

UPDATE ON MEDICAL TREATMENT OF OSTEOARTHRITIS

The management plan should be individualized. Nonpharmacologic treatments of osteoarthritis (OA) include education, weight management and appropriate exercise which may delay disease progression, reduce symtoms, and improve fuction. Nutritional supplements such as glucosamine and chondroitin sulfate have been studied in OA, may benefit some patients, and have low toxicity. Pharmacologic approaches to treatment include non-narcotic analgesics such as acetaminophen and nonsteroid anti-imflammatory drugs (NSAIDs). Intra-articular injection of glucocorticoids or hyaluronic may be useful for isolated joint involvement. Surgical joint replacement, especially at the hip and knee, can reduce pain and improve function in appropriate candidates. Investigation continues into potential disease-modifying interventions in OA. Key words: osteoarthritis